• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ganymed Pharmaceuticals AG - Articles and news items

IMAB362

Ganymed’s IMAB362 to bring hope to gastric cancer patients, says GlobalData

Industry news / 16 June 2016 / Victoria White, Digital Content Producer

New data on IMAB362 provides hope for a subset of gastric and gastroesophageal junction adenocarcinoma patients, according to GlobalData…

IMAB362

IMAB362 extends survival in gastric cancer

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Ganymed announced data from its randomised Phase II clinical study of IMAB362 in first-line treatment of gastric cancer at the ASCO 2016 Annual Meeting…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +